[go: up one dir, main page]

FI891210A0 - Tiosulfinsyraderivat, deras anvaendning vid inflammationssjukdomar samt laekemedel innehaollande dessa aemnen. - Google Patents

Tiosulfinsyraderivat, deras anvaendning vid inflammationssjukdomar samt laekemedel innehaollande dessa aemnen.

Info

Publication number
FI891210A0
FI891210A0 FI891210A FI891210A FI891210A0 FI 891210 A0 FI891210 A0 FI 891210A0 FI 891210 A FI891210 A FI 891210A FI 891210 A FI891210 A FI 891210A FI 891210 A0 FI891210 A0 FI 891210A0
Authority
FI
Finland
Prior art keywords
thiosulfinsyraderivat
inflammationssjukdomar
laekemedel
aemnen
samt
Prior art date
Application number
FI891210A
Other languages
English (en)
Finnish (fi)
Other versions
FI891210A (fi
Inventor
Walter Dorsch
Hildebert Wagner
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI891210A publication Critical patent/FI891210A/fi
Publication of FI891210A0 publication Critical patent/FI891210A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI891210A 1987-07-14 1989-03-14 Tiosulfinsyraderivat, deras anvaendning vid inflammationssjukdomar samt laekemedel innehaollande dessa aemnen. FI891210A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873723248 DE3723248A1 (de) 1987-07-14 1987-07-14 Verwendung von thiosulfinsaeurederivaten zur behandlung von entzuendungserkrankungen
PCT/EP1988/000628 WO1989000422A2 (en) 1987-07-14 1988-07-12 Thiosulphinic acid derivatives, their use in the treatment of inflammatory diseases, and drugs containing them

Publications (2)

Publication Number Publication Date
FI891210A FI891210A (fi) 1989-03-14
FI891210A0 true FI891210A0 (fi) 1989-03-14

Family

ID=6331547

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891210A FI891210A0 (fi) 1987-07-14 1989-03-14 Tiosulfinsyraderivat, deras anvaendning vid inflammationssjukdomar samt laekemedel innehaollande dessa aemnen.

Country Status (11)

Country Link
US (1) US5321045A (da)
EP (2) EP0324023A1 (da)
JP (1) JPH01503713A (da)
KR (1) KR890701096A (da)
AT (1) ATE96024T1 (da)
AU (1) AU621058B2 (da)
DE (2) DE3723248A1 (da)
DK (1) DK113789A (da)
FI (1) FI891210A0 (da)
HU (1) HU208114B (da)
WO (1) WO1989000422A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976548A (en) * 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
FR2813884B1 (fr) * 2000-09-12 2004-01-16 Critt Innophyt Procede de fabrication de thiosulfinates et dispositif de mise en oeuvre du procede
DE10132003A1 (de) * 2001-07-03 2003-01-30 Merz & Co Gmbh & Co Fett(öl)haltiges Mittel, enthaltend Zwiebelextrakt, seine Herstellung und seine Verwendung zur Pflege, Vorbeugung oder Behandlung von geschädigtem Hautgewebe, insbesondere von Narben
US20030077264A1 (en) * 2001-09-20 2003-04-24 Goodrich Laura L. Antimicrobial blood treatment using allicin and related compounds
EP1832575A1 (en) * 2006-03-06 2007-09-12 Sulfidris S.r.l. Anti-inflammatory agents
CA2837526C (en) 2011-06-24 2019-07-09 Merz Pharma Gmbh & Co. Kgaa Composition comprising an onion extract and liposomes
CN109394746A (zh) * 2017-08-15 2019-03-01 江西青峰药业有限公司 乙基硫酸铵在制备用于预防或治疗炎症性疾病药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2508745A (en) * 1946-12-18 1950-05-23 Sterling Drug Inc Hydrocarbon esters of hydrocarbonylthiolsulfinic acids and their process of preparation
JPS4927193B1 (da) * 1965-11-24 1974-07-16
BE754968A (nl) * 1969-08-18 1971-02-18 Int Flavors & Fragrances Inc Werkwijze voor de bereiding van lookaroma's, alsmede voor het verlenen van een look-aroma aan een voedingsmiddel
DE3305951A1 (de) * 1983-02-21 1984-08-23 Walter Dr Dorsch Arzneimittel zur behandlung des asthma bronchiale
EP0153881A2 (en) * 1984-03-02 1985-09-04 The Johns Hopkins University Treatment of allergies and inflammatory conditions

Also Published As

Publication number Publication date
AU2126288A (en) 1989-02-13
DK113789D0 (da) 1989-03-08
AU621058B2 (en) 1992-03-05
EP0299424A2 (de) 1989-01-18
EP0324023A1 (de) 1989-07-19
DE3885022D1 (de) 1993-11-25
DK113789A (da) 1989-03-08
EP0299424B1 (de) 1993-10-20
WO1989000422A3 (fr) 1989-03-09
FI891210A (fi) 1989-03-14
ATE96024T1 (de) 1993-11-15
HU208114B (en) 1993-08-30
WO1989000422A2 (en) 1989-01-26
US5321045A (en) 1994-06-14
DE3723248A1 (de) 1989-01-26
EP0299424A3 (en) 1989-10-18
JPH01503713A (ja) 1989-12-14
KR890701096A (ko) 1989-12-19

Similar Documents

Publication Publication Date Title
NO901372D0 (no) Framgangsmaate for tilvirking av medikament-baerer.
FI874671A (fi) Anordning foer foerhindrande av laeckage i tryckledningar.
DE3883985D1 (de) Ärztliches instrument und dessen herstellung.
NO304793B1 (no) nor-gallesyrederivater, og anvendelse av dem for fremstilling av legemiddel
FI881177A (fi) Anordning foer positionering av en patient i en medicinsk panoramaroentgenfotograferingsanordning.
FI875326A (fi) Ljusbestraolningsanordning foer medicinal vaord av oera.
NO883475D0 (no) Fremgangsmaate for fremstilling av antibakterielle kinoloner.
DK644388D0 (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
NO894499L (no) Fremgangsmaate for separering av folinsyre.
IT1238684B (it) Derivati del bilobalide,loro usi e formulazioni che li contegono
DE3884870D1 (de) Verfahren zur Herstellung von Vitamin-D-Derivaten.
FI891210A0 (fi) Tiosulfinsyraderivat, deras anvaendning vid inflammationssjukdomar samt laekemedel innehaollande dessa aemnen.
IT8721687A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropiridin-3-carbossa ldeide, loro procedimento di preparazione e loro impiego come sostanze medicinali.
DE3786562D1 (de) 2,6-dideoxy-2-fluoro-l-talopyranose, derivate davon und herstellung dieser verbindungen.
NO881255D0 (no) Behandling av fluider.
ATE37871T1 (de) Substituierte azabicycloalkane, ihre verwendung, pharmazeutische praeparate, welche diese verbindungen enthalten, und verfahren zur herstellung dieser verbindungen.
FI894921A0 (fi) Anordning foer foertunnande av kanten vid en kartongbana eller -ark.
NO884062D0 (no) Desinfeksjon av avforminger.
DE69305250D1 (de) Herstellung von Alkandicarbonsäurederivaten
NO922635D0 (no) Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater
IT1212552B (it) Alcanolaminossi derivati di 3,4-diidro-2h-1.4-benzotiazin-3-one, loro procedimento di produzione e loro utilizzazione farmaceutica
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DE3888697D1 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
ATE3851T1 (de) Monochlorcitronensaeurederivate, diese enthaltende pharmazeutische praeparate und verfahren zur herstellung dieser derivate.
FI881065A0 (fi) Foerfarande foer framstaellning av naftalenfoereningar anvaendbara vid behandling av psoriasis.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: BOEHRINGER MANNHEIM GMBH